Sarepta Therapeutics
SRPT
SRPT
371 hedge funds and large institutions have $8.48B invested in Sarepta Therapeutics in 2019 Q1 according to their latest regulatory filings, with 72 funds opening new positions, 142 increasing their positions, 115 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
11% more funds holding
Funds holding: 335 → 371 (+36)
1.01% less ownership
Funds ownership: 97.5% → 96.48% (-1%)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Holders
371
Holding in Top 10
5
Calls
$363M
Puts
$283M
Top Buyers
| 1 | +$104M | |
| 2 | +$98.5M | |
| 3 | +$76.5M | |
| 4 |
Sands Capital Management
Arlington,
Virginia
|
+$62.3M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$46.7M |
Top Sellers
| 1 | -$100M | |
| 2 | -$83.5M | |
| 3 | -$78.4M | |
| 4 |
FAM
Fred Alger Management
New York
|
-$71.8M |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
-$40.4M |